Peer-reviewed veterinary case report
The changing landscape of antiparasitic drug discovery for veterinary medicine.
- Journal:
- Trends in parasitology
- Year:
- 2004
- Authors:
- Geary, Timothy G et al.
Plain-English summary
Recent changes in the pharmaceutical industry have led to fewer resources being dedicated to developing new antiparasitic drugs for pets and livestock. This is a concern because we need innovative treatments to tackle issues like drug resistance and other problems that haven't been addressed yet. To move forward, the industry will need to adopt new scientific methods and business approaches. Importantly, more support is needed for basic research into how parasites work, which is crucial for creating effective new medications. Overall, the future of antiparasitic drug development in veterinary medicine depends on these changes.
Abstract
Changes in economic imperatives in the pharmaceutical industry have led to a wave of consolidation, which has had the unintended side effect of shrinking the resource devoted to antiparasitic drug discovery in animal health companies. Scientific changes have altered the way in which drugs could be discovered in the future. New science and business models will need to be implemented to address the demand for innovative antiparasitic drugs in veterinary medicine. Novel drugs are needed to combat drug resistance and for currently non-addressed problems. At the center of the future for this field, however, lies the need for more support into the basic research on the biology of parasites.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/15363437/